sarcopenia glp 1 Balancing weight and muscle loss in GLP1 receptor agonist therapy GLP1 #Semaglutide #Sarcopenia #MetabolicHealth #HealthLongevitySecrets
Description
All other authors declare that there are no relationships or activities that might bias, or be perceived to bias, their contribution to this manuscript
Specific to cardiovascular-related death, ELIXA and SUSTAIN-6 trials showed similar performance relative to the placebo [ HR = 0.98 (95% CI 0.781.22) and HR = 0.98 (95% CI 0.651.48), respectively]
Because the future beauty consumer may not be buying anti-aging. They may be buying post-change confidence. One of the most under-discussed consequences of GLP-1 weight loss is lean mass loss
Prioritize peri-workout nutrition and hydration
